Hyderabad-based GCBC Vaccines has received WHO reapproval for its oral cholera vaccine, Shanchol, originally developed by Shantha Biotechnics. The move revives India’s role in ensuring global vaccine supply and supports public health efforts against recurring cholera outbreaks.
Study findings have been published in the Science Direct, Vaccine journal 126998 to assess a double-blind, randomised phase III clinical trial to evaluate safety, immunogenicity, non-inferiority and lot-to-lot consistency of single component oral cholera vaccine
A report by UN showed that after years of steady decline, cholera is making a devastating comeback and targeting the world's most vulnerable communities
The latest case, reported on Tuesday, is the husband of the first confirmed patient, the provincial health department said in a statement on Wednesday.
The Ministry noted that the infection was detected in the northern governorate of Akkar, and the patient is receiving treatment at the hospital and is in stable condition, Xinhua news agency reported.
Amaravati: Five people died of cholera in the Amravati district of Maharashtra and as many as 181 patients have been diagnosed with the disease, the state public health department confirmed. Among the deceased, two were women and three were men. Three of these patients were in the age group 24 to 40 years and two […]
